Showing 361-370 of 4005 results for "".
Double Take: Pivotal Data Evaluating PI3K Inhibitor/Endocrine Therapy Regimens in mBC
https://reachmd.com/programs/cme/Double-Take-Pivotal-Data-Evaluating-PI3K-Inhibitor-Endocrine-Therapy-Regimens-in-mBC/37333/Join Drs. Jhaveri and Kalinsky and get up to speed on the latest data on PI3K-directed therapies and their role in the treatment paradigm for HR+, HER2- mBC.Case in Point: Applying PI3K Combinations in Early Recurrent HR+/HER2- mBC
https://reachmd.com/programs/cme/Case-in-Point-Applying-PI3K-Combinations-in-Early-Recurrent-HR-HER2-mBC/37336/Join Drs. Jhaveri and Kalinsky and get up to speed on the latest data on PI3K-directed therapies and their role in the treatment paradigm for HR+, HER2- mBC.Understanding Endocrine Resistance in HR+/HER2- mBC
https://reachmd.com/programs/cme/Understanding-Endocrine-Resistance-in-HR-HER2-mBC/37323/Join Drs. Jhaveri and Kalinsky and get up to speed on the latest data on PI3K-directed therapies and their role in the treatment paradigm for HR+, HER2- mBC.PI3K Pathway Inhibition in HR+/HER2- mBC: Mechanistic Insights
https://reachmd.com/programs/cme/PI3K-Pathway-inhibition-in-HR-HER2-mBC-Mechanistic-Insights/37329/Join Drs. Jhaveri and Kalinsky and get up to speed on the latest data on PI3K-directed therapies and their role in the treatment paradigm for HR+, HER2- mBC.Technology and Instant Communication: New Visions for Primary Care
https://reachmd.com/programs/clinicians-roundtable/technology-and-instant-communication-new-visions-for-primary-care/4110/A relatively new primary care practice based in Brooklyn, New York, is using new ways to serve the un- and under-insured communities in its own neighborhood. The practice, Hello Health, is based on membership and pay-per-visit office fees from patients instead of insurance, and encourages patients tDysfunctions in US Healthcare
https://reachmd.com/programs/clinicians-roundtable/dysfunctions-in-us-healthcare/3202/We all know that our healthcare system is far from perfect. But where should we begin to make repairs? Host Dr. Leslie Lundt welcomes John Nance, author of Why Hospitals Should Fly: The Ultimate Flight Plan to Patient Safety and Quality Care, to outline the major dysfunctions of the system. The firsTo Admit or Observe: What Would CMS Say?
https://reachmd.com/programs/clinicians-roundtable/to-admit-or-observe-what-would-cms-say/2878/Whether to admit or observe a ER patient is not always clear cut. What criteria should you use to make this decision? How can you be sure that your decision process will be supported and covered by CMS? What if CMS isn’t ultimately willing to pay for the services? Join host Dr. Bill Rutenberg inServices to Encourage More Involved, Informed Patients
https://reachmd.com/programs/clinicians-roundtable/services-to-encourage-more-involved-informed-patients/4850/Informed decision-making involves helping patients arrive at the questions that can ultimately help their doctors deliver the best possible medical care. Jeff Belkora, director of Decision Services at the University of California San Francisco Breast Care Center, a demonstration program of the FoundExecutive Physicals: Harmful to Health?
https://reachmd.com/programs/clinicians-roundtable/executive-physicals-harmful-to-health/3901/Executive physicals are marketed widely as the ultimate medical checkups for discerning consumers. Dr. Brian Rank, the medical director of HealthPartners Medical Group and Clinics of Minnesota, discusses with host Dr. Larry Kaskel the basis for his belief that the popularity of executive physicals iA Doctor's Opinion on Pharma Education
https://reachmd.com/programs/clinicians-roundtable/a-doctors-opinion-on-pharma-education/2399/Dr. Daniel Carlat has written in a New York Times article called, “Dr. Drug Rep”, that allowing pharmaceutical companies to sponsor medical education leads to many bad things, including biased education, corrupt physicians, and, ultimately, harm to our patients. Host Dr. Leslie Lundt listens to what